financetom
Business
financetom
/
Business
/
FRESHBREW ACQUIRES LARGEST LICENSED BRANDED COFFEE PORTFOLIO IN THE NATION FROM WHITE COFFEE CORPORATION
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FRESHBREW ACQUIRES LARGEST LICENSED BRANDED COFFEE PORTFOLIO IN THE NATION FROM WHITE COFFEE CORPORATION
Oct 14, 2025 7:19 AM

85-year-old White Coffee Corp., a leading supplier to major discount and big box retailers, offers a new licensed division of retail business and brand opportunities

HOUSTON, Oct. 14, 2025 /PRNewswire/ -- Houston-based FreshBrew, one of the largest private-label coffee and tea roasters in the country, announced today the acquisition of White Coffee's Branded Coffee licensed division, which includes the nation's largest portfolio of licensed bagged coffee and K-Cup® products.

"FreshBrew is expanding its capabilities and growing the business," said Al Ansari, CEO of FreshBrew Group. "Acquiring a respected, family-led company like this presented a rare opportunity to strengthen our position in the coffee industry. Now is the perfect time to join forces, as FreshBrew continues to grow with purpose. This move expands our offerings and diversifies our customer and consumer base."

FreshBrew will secure ownership of multiple licenses, enabling the company to develop, produce, and market coffee for major brands with established market presence. Leveraging the strong brand equity of these licensed names, FreshBrew will handle the entire process, from roasting and grinding to distribution, complementing FreshBrew's private label business.

"Our company has been our family's life for decades," said Carole White, President of White Coffee Corp. "Seeing our brands and licensed partnerships carried forward by FreshBrew ensures that White Coffee's history of quality and care will live on for future generations of coffee drinkers."

The acquisition of White Coffee represents one of the largest transactions in the coffee industry in 2025. FreshBrew, which proudly serves a portfolio of renowned Fortune 500 companies, will significantly expand its operations to produce approximately 150,000 pounds of coffee per day. With the addition of its new liquid production facility, FreshBrew now has the capability to produce extracts and a variety of concentrates for use across the food and beverage industry.

"All three generations of our family have dedicated themselves to building the White Coffee legacy. Handing the stewardship of our branded portfolio to FreshBrew is a proud and emotional milestone," said Jonathan White, Executive Vice President of White Coffee Corp and Chair of the National Coffee Association's Board of Directors.

Jonathan and Gregory White, Vice President of White Coffee Corp., will join FreshBrew's executive team to lead the transition and focus on growing the retail division and all facets of the business. 

About Fresh Brew Group

FreshBrew is a family-owned business operating FreshBrew Coffee and Tea. Since its inception more than 90 years ago, FreshBrew has been dedicated to providing customers with the highest quality product and technology-driven services while continuously expanding product lines. As one of the largest private-label coffee and tea producers in the country, FreshBrew supplies coffee, tea and total beverage solutions to notable brands in the national foodservice, convenience store, hospitality and retail sectors.

For more information, visit www.freshbrewgroup.com

About White Coffee Corp.

Founded in 1939 and headquartered in Long Island City, NY, White Coffee Corp. has been family-owned and operated for three generations. Known for its innovation, quality, and one of the nation's largest licensed coffee portfolios, White Coffee has built a reputation as a trusted partner to retailers, foodservice providers, and consumers nationwide.

View original content to download multimedia:https://www.prnewswire.com/news-releases/freshbrew-acquires-largest-licensed-branded-coffee-portfolio-in-the-nation-from-white-coffee-corporation-302583158.html

SOURCE FreshBrew

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sentinelone Insider Sold Shares Worth $1,140,682, According to a Recent SEC Filing
Sentinelone Insider Sold Shares Worth $1,140,682, According to a Recent SEC Filing
Sep 11, 2024
05:00 PM EDT, 09/10/2024 (MT Newswires) -- Ric Smith, Chief Product & Technology Officer, on September 06, 2024, sold 51,052 shares in Sentinelone ( S ) for $1,140,682. Following the Form 4 filing with the SEC, Smith has control over a total of 585,647 shares of the company, with 585,647 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1583708/000158370824000078/xslF345X05/wk-form4_1726001520.xml ...
Westaim Completes US$79-Million Sale of Remaining Interest in Skyward Specialty Insurance
Westaim Completes US$79-Million Sale of Remaining Interest in Skyward Specialty Insurance
Sep 11, 2024
05:02 PM EDT, 09/10/2024 (MT Newswires) -- Westaim ( WEDXF ) after trade Tuesday said it sold all its remaining 1.91-million shares in Skyward Specialty Insurance Group. The investment-holding company said proceeds, less commissions, were approximately US$79 million. Westaim's ( WEDXF ) remaining investments include significant interests in Arena and the Arena FINCOs. The company's shares closed down $0.04 to...
Abercrombie & Fitch Insider Sold Shares Worth $2,501,264, According to a Recent SEC Filing
Abercrombie & Fitch Insider Sold Shares Worth $2,501,264, According to a Recent SEC Filing
Sep 11, 2024
05:10 PM EDT, 09/10/2024 (MT Newswires) -- Samir Desai, Executive Vice President, Chief Digital & Technology Officer, on September 06, 2024, sold 19,041 shares in Abercrombie & Fitch ( ANF ) for $2,501,264. Following the Form 4 filing with the SEC, Desai has control over a total of 27,985 shares of the company, with 27,985 shares held directly. SEC Filing:...
BridgeBio to stop development of therapy for genetic disorder
BridgeBio to stop development of therapy for genetic disorder
Sep 11, 2024
Sept 10 (Reuters) - BridgeBio Pharma ( BBIO ) said on Tuesday it will stop development of its experimental therapy for a genetic disease that affects the adrenaline-producing gland. The drugmaker said the results of its early-to-mid stage study testing the therapy did not meet the threshold to warrant additional capital investment. (Reporting by Puyaan Singh; Editing by Shinjini Ganguli)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved